{"slideshow_credits": null, "snippet": "Forest Laboratories agreed to be sold to Actavis in a cash and stock deal to create a company with heavy exposure to branded and generic drugs.", "abstract": "Forest Laboratories agreed to be sold to Actavis in a cash and stock deal to create a company with heavy exposure to branded and generic drugs.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}, {"firstname": "William", "role": "reported", "lastname": "ALDEN", "rank": 2, "organization": ""}], "original": "By DAVID GELLES and WILLIAM ALDEN"}, "web_url": "http://dealbook.nytimes.com/2014/02/18/drug-makers-in-25-billion-deal/", "lead_paragraph": null, "headline": {"main": "Icahn Orchestrates $25 Billion Drug Merger ", "print_headline": "Icahn Orchestrates $25 Billion Drug Merger", "kicker": "DealBook"}, "_id": "5303549838f0d821d3f24a78", "word_count": "1185", "multimedia": [{"height": 126, "url": "images/2014/02/19/business/DRUG/DRUG-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/02/19/business/DRUG/DRUG-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/02/19/business/DRUG/DRUG-articleLarge.jpg", "legacy": {"xlarge": "images/2014/02/19/business/DRUG/DRUG-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/02/19/business/DRUG/DRUG-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/02/19/business/DRUG/DRUG-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-02-18T07:37:42Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Icahn, Carl C", "rank": "1"}, {"name": "organizations", "value": "Forest Laboratories Inc", "rank": "2"}, {"name": "organizations", "value": "Actavis Group", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}